← FDA DRUG APPROVALS

FDA ANDA · ANDA074125

PINDOLOL

Sponsor: PUREPAC PHARM

APPLICATION
ANDA074125
TYPE
ANDA
ORIGINAL APPROVAL
1993-04-28
LATEST ACTION
1993-05-17
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

PINDOLOLDiscontinued
PINDOLOL 5MG · TABLET · ORAL
PINDOLOLDiscontinued
PINDOLOL 10MG · TABLET · ORAL

Approval history

1993-05-17Labeling · Supplement 1AP
1993-04-28OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →